Showing results (311-320 of 686) with videos related to

Sort By:
Pageof 69
Journal of Lipid Research|March 30, 2016
Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obesePuneet Puri, Jun Xu, Terhi Vihervaara, et al.
Hepatology Communications|April 8, 2020
Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic HepatitisWei Li, Ying Xia, Jing Yang, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early deathDouglas M Heuman, Souheil G Abou-Assi, Adil Habib, et al.
Indian Heart Journal|October 22, 2017
Under-utilization of pacemaker therapy for sinus node dysfunction - Real world data from South AsiaC Narasimhan, J Sanyal, R Sethi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2004
Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfectionRichard K Sterling, Mary S Wilson, Arun J Sanyal, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2024
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE TrialPhilip N Newsome, Arun J Sanyal, Kristiane A Engebretsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancerFaridoddin Mirshahi, Hussein F Aqbi, Kellen Cresswell, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2011
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1Thomas D Boyer, Arun J Sanyal, Guadalupe Garcia-Tsao, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2025
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients With MASHLouise Maymann Nitze, Vlad Ratziu, Arun J Sanyal, et al.
Pageof 69